News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Palatin Tech (PTN) To Report First Quarter Fiscal Year 2017 Results; Teleconference And Webcast To Be Held On November 15, 2016



11/11/2016 2:00:11 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs

CRANBURY, N.J., Nov. 10, 2016 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its first quarter, fiscal year 2017 operating results on Tuesday, November 15, 2016  before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 15, 2016 at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast

Q1 Fiscal Year 2017 Financial Results Press Release       

11/15/2016 at 7:30 a.m. ET



Q1 Fiscal Year 2017 Conference Call-Live              

11/15/2016 at 11:00 a.m. ET

Domestic Dial-In Number:                               

1-888-503-8171

International Dial-In Number:                          

1-719-457-2664

Conference ID:                                         

9405459



Q1 Fiscal Year 2017 Conference Call-Replay             

11/15/2016-11/22/2016

Domestic Dial-In Number:                            

1-888-203-1112

International Dial-In Number:                            

1-719-457-0820

Replay Passcode:                                     

9405459



Audio Webcast Live and Replay Access          

http://www.palatin.com

The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com.

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/palatin-technologies-inc-to-report-first-quarter-fiscal-year-2017-results-teleconference-and-webcast-to-be-held-on-november-15-2016-300360364.html

SOURCE Palatin Technologies, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES